Can Endothelial Glycocalyx Be A Major Morphological Substrate in Pre-Eclampsia?

• Main Authors: Marina M. Ziganshina, Ekaterina L. Yarotskaya, Nicolai V. Bovin, Stanislav V. Pavlovich, Gennady T. Sukhikh
• Format: Article
• Language: English
• Published: MDPI AG 2020-04-01
• Series: International Journal of Molecular Sciences
• Subjects: pregnancy; pre-eclampsia; endothelium; endothelial glycocalyx; systemic inflammatory response
• Online Access: https://www.mdpi.com/1422-0067/21/9/3048
• ISSN: 1661-6596; 1422-0067

<b> </b>Today pre-eclampsia (PE) is considered as a disease of various theories; still all of them agree that endothelial dysfunction is the leading pathogenic factor. Endothelial dysfunction is a sequence of permanent immune activation, resulting in the change of both the phenotype and the functions of an endothelial cell and of the extracellular layer associated with the cell membrane—endothelial glycocalyx (eGC). Numerous studies demonstrate that eGC mediates and regulates the key functions of endothelial cells including regulation of vascular tone and thromboresistance; and these functions are disrupted during PE. Taking into account that eGC and its components undergo alterations under pathological conditions leading to endothelial activation, it is supposed that eGC plays a certain role in pathogenesis of PE. Envisaging the eGC damage as a key factor of PE, might be a new approach to prevention, treatment, and rehabilitation of patients with PE. This approach could include the development of drugs protecting eGC and promoting regeneration of this structure. Since the issue of PE is far from being solved, any effort in this direction might be valuable.